Showing 1 - 10 of 73
While recent research has explored the phenomenon of drug parallel trade in regulated environments such as the European … is price differences across countries, the propagation mechanism lies in (a) the way drug prices are regulated across … drug prices are regulated. The implications that flow from our study are that a more flexible and competitive and less …
Persistent link: https://www.econbiz.de/10010745350
Assessing the value of new medical technologies may require new approaches that take into account a more comprehensive set of parameters than the incremental cost/QALY. It is argued that MCDA can fulfil this role and has the potential to be methodologically superior to the currently used...
Persistent link: https://www.econbiz.de/10010884583
This paper explores the changing role of government involvement in health care financing policy outside the United States. It provides a review of the economics literature in this area to elucidate the implications of recent policy changes on efficiency, costs, and quality. Our review reveals...
Persistent link: https://www.econbiz.de/10011126077
This paper investigates the determinants of the prices of branded prescription medicines across different regulatory settings and health care systems, taking into account their launch date, patent status, market dynamics and the regulatory context in which they diffuse. By using volume-weighted...
Persistent link: https://www.econbiz.de/10010884744
The impacts of choice in public services are controversial. We exploit a reform in the English National Health Service to assess the impact of relaxing constraints on patient choice. We estimate a demand model to evaluate whether increased choice increased demand elasticity faced by hospitals...
Persistent link: https://www.econbiz.de/10010745562
constitutions: non-profit cooperatives and outside ownership. In the former, ownership is shared among a group of consumers on a one …
Persistent link: https://www.econbiz.de/10010928786
This paper studies how patent rights and price regulation affect how fast new drugs are launched in different countries, using newly constructed data on launches of 642 new drugs in 76 countries for the period 1983-2002, and information on the duration and content of patent and price control...
Persistent link: https://www.econbiz.de/10011126137
To overcome the problem of insufficient research and development (R&D) on vaccines for diseases concentrated in low-income countries, sponsors could commit to purchase viable vaccines if and when they are developed. One or more sponsors would commit to a minimum price that would be paid per...
Persistent link: https://www.econbiz.de/10011071268
In the European Union, medicines are regulated products subject to both single market (e.g., regional exhaustion of property rights) and country specific health care regulations (e.g., medicines pricing). This gives rise to parallel trade (PT), a phenomenon that takes place when a patented...
Persistent link: https://www.econbiz.de/10011171762
means. We develop a model in which a CEO's ownership stake and private benefits have opposite effects on his willingness to … optimally commit to a low monitoring intensity when either CEO ownership is low or private benefits are high. Our model suggests … that the existing cross-section evidence on the correlation between board composition and CEO ownership and tenure needs re …
Persistent link: https://www.econbiz.de/10011126080